Articles
Doctors just found a way to slow one of the deadliest prostate cancers
A targeted drug combo slashes prostate cancer progression and ushers in a new era of personalised treatment.
In the large AMPLITUDE trial, patients receiving the combo lived longer without symptoms worsening and saw nearly a 50% risk reduction in BRCA-mutated cases.
Click here to access the article.